38 Rowland Street
Level 2 Subiaco
Perth, WA 6008
Australia
61 8 6382 0137
https://www.invextherapeutics.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Ms. Narelle Warren B.Com., L.L.B., B.Com, LLB | CFO & Company Secretary | 135k | N/A | N/A |
Dr. Thomas Duthy M.B.A., Ph.D. | Executive Director | 180k | N/A | N/A |
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. The company is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. Invex Therapeutics Ltd was incorporated in 2019 and is based in Perth, Australia.
Invex Therapeutics Ltds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.